BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bouvier NM. The Future of Influenza Vaccines: A Historical and Clinical Perspective. Vaccines (Basel) 2018;6:E58. [PMID: 30200179 DOI: 10.3390/vaccines6030058] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang CQ, Chung PK, Liu JD, Chan DKC, Hagger MS, Hamilton K. Health Beliefs of Wearing Facemasks for Influenza A/H1N1 Prevention: A Qualitative Investigation of Hong Kong Older Adults. Asia Pac J Public Health 2019;31:246-56. [PMID: 31007032 DOI: 10.1177/1010539519844082] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
2 Richards KA, Moritzky S, Shannon I, Fitzgerald T, Yang H, Branche A, Topham DJ, Treanor JJ, Nayak J, Sant AJ. Recombinant HA-based vaccine outperforms split and subunit vaccines in elicitation of influenza-specific CD4 T cells and CD4 T cell-dependent antibody responses in humans. NPJ Vaccines 2020;5:77. [PMID: 32884842 DOI: 10.1038/s41541-020-00227-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
3 Nelson SA, Dileepan T, Rasley A, Jenkins MK, Fischer NO, Sant AJ. Intranasal Nanoparticle Vaccination Elicits a Persistent, Polyfunctional CD4 T Cell Response in the Murine Lung Specific for a Highly Conserved Influenza Virus Antigen That Is Sufficient To Mediate Protection from Influenza Virus Challenge. J Virol 2021;95:e0084121. [PMID: 34076479 DOI: 10.1128/JVI.00841-21] [Reference Citation Analysis]
4 Betancourt-Cravioto M, Falcón-Lezama JA, Saucedo-Martínez R, Alfaro-Cortés MM, Tapia-Conyer R. Public Health and Economic Benefits of Influenza Vaccination of the Population Aged 50 to 59 Years without Risk Factors for Influenza Complications in Mexico: A Cross-Sectional Epidemiological Study. Vaccines (Basel) 2021;9:188. [PMID: 33668199 DOI: 10.3390/vaccines9030188] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Fiege JK, Block KE, Pierson MJ, Nanda H, Shepherd FK, Mickelson CK, Stolley JM, Matchett WE, Wijeyesinghe S, Meyerholz DK, Vezys V, Shen SS, Hamilton SE, Masopust D, Langlois RA. Mice with diverse microbial exposure histories as a model for preclinical vaccine testing. Cell Host Microbe 2021:S1931-3128(21)00463-7. [PMID: 34731647 DOI: 10.1016/j.chom.2021.10.001] [Reference Citation Analysis]
6 Paramsothy A, Lartey Jalloh S, Davies RA, Guttormsen AB, Cox RJ, Mohn KG. Humoral and cellular immune responses in critically ill influenza A/H1N1-infected patients. Scand J Immunol 2021;94:e13045. [PMID: 33891354 DOI: 10.1111/sji.13045] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Lim WW, Leung NHL, Sullivan SG, Tchetgen Tchetgen EJ, Cowling BJ. Distinguishing Causation From Correlation in the Use of Correlates of Protection to Evaluate and Develop Influenza Vaccines. Am J Epidemiol 2020;189:185-92. [PMID: 31598648 DOI: 10.1093/aje/kwz227] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
8 Nelson SA, Sant AJ. Imprinting and Editing of the Human CD4 T Cell Response to Influenza Virus. Front Immunol 2019;10:932. [PMID: 31134060 DOI: 10.3389/fimmu.2019.00932] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
9 Moore KA, Ostrowsky JT, Kraigsley AM, Mehr AJ, Bresee JS, Friede MH, Gellin BG, Golding JP, Hart PJ, Moen A, Weller CL, Osterholm MT; Influenza Vaccines R&D Roadmap Taskforce. A Research and Development (R&D) roadmap for influenza vaccines: Looking toward the future. Vaccine 2021;39:6573-84. [PMID: 34602302 DOI: 10.1016/j.vaccine.2021.08.010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Madsen A, Cox RJ. Prospects and Challenges in the Development of Universal Influenza Vaccines. Vaccines (Basel) 2020;8:E361. [PMID: 32640619 DOI: 10.3390/vaccines8030361] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
11 Liu WC, Nachbagauer R, Stadlbauer D, Solórzano A, Berlanda-Scorza F, García-Sastre A, Palese P, Krammer F, Albrecht RA. Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model. Front Immunol 2019;10:756. [PMID: 31105689 DOI: 10.3389/fimmu.2019.00756] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 10.7] [Reference Citation Analysis]
12 Arefin MR, Masaki T, Kabir KMA, Tanimoto J. Interplay between cost and effectiveness in influenza vaccine uptake: a vaccination game approach. Proc Math Phys Eng Sci 2019;475:20190608. [PMID: 31892839 DOI: 10.1098/rspa.2019.0608] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
13 Rajaram S, Boikos C, Gelone DK, Gandhi A. Influenza vaccines: the potential benefits of cell-culture isolation and manufacturing. Ther Adv Vaccines Immunother 2020;8:2515135520908121. [PMID: 32128506 DOI: 10.1177/2515135520908121] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
14 Kang SJ, Jung SI. Age-Related Morbidity and Mortality among Patients with COVID-19. Infect Chemother 2020;52:154-64. [PMID: 32537961 DOI: 10.3947/ic.2020.52.2.154] [Cited by in Crossref: 120] [Cited by in F6Publishing: 104] [Article Influence: 60.0] [Reference Citation Analysis]
15 Heffernan DS. Influenza and the Surgeon. Surg Infect (Larchmt) 2019;20:119-28. [PMID: 30724707 DOI: 10.1089/sur.2019.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
16 Falcón-Lezama JA, Saucedo-Martínez R, Betancourt-Cravioto M, Alfaro-Cortes MM, Bahena-González RI, Tapia-Conyer R. Influenza in the school-aged population in Mexico: burden of disease and cost-effectiveness of vaccination in children. BMC Infect Dis 2020;20:240. [PMID: 32197591 DOI: 10.1186/s12879-020-4948-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]